University of Kansas Medical Center (KUMC) is a clinical research site located in Kansas City, Kansas, United States 66160.
Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Kansas Medical Center (KUMC) has participated in 18 clinical trials with 8 currently active.
Therapeutic areas: Diabetic Gastroparesis, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM), Familial Chylomicronemia Syndrome.
Sponsors: CinDome Pharma, Inc., Ionis Pharmaceuticals, Inc., Tyra Biosciences, Inc.
Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Kansas Medical Center (KUMC) has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Kansas Medical Center (KUMC) has 18 clinical trials on record, with 8 currently active. Their work covers Diabetic Gastroparesis, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM), Familial Chylomicronemia Syndrome.
Yes — University of Kansas Medical Center (KUMC) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.